CMRX

AS OF

Apr 17 closing price

Price

$8.54

Change

-$0.01 (-0.12%)

Capitalization

801.08M

72 days until earnings call

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

CMRX Stock CMRX is expected to report earnings to fall -6.68% to -27 cents per share on May 01

GET DAILY SIGNALS

Get AI intraday signals

A.I.dvisor
at Tickeron.com

Buy or Sell

View Daily Signals

CMRX - Chimerix

Q1'25

Est.

$-0.27

Q4'24

Est.

$-0.25

Q3'24

Missed

by $0.02

Q2'24

Est.

$-0.23

Q1'24

Missed

by $0.04

The last earnings report on December 31 showed earnings per share of -25 cents, meeting the estimate of -25 cents. P/B Ratio (6.583) is normal, around the industry mean (14.373). P/E Ratio (0.000) is within average values for comparable stocks, (64.619). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.850). Dividend Yield (0.000) settles around the average of (0.023) among similar stocks. CMRX's P/S Ratio (3333.333) is very high in comparison to the industry average of (255.161). With 755.56K shares outstanding, the current market capitalization sits at 801.08M.

View a ticker or compare two or three

Compare

Interact to see
Advertisement

A.I.Advisor

published price charts

View to see Real Time Patterns for CMRX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of novel oral antiviral therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2505 Meridian Parkway

Phone

+1 919 806-1074

Employees

Web

https://www.chimerix.com